Dong-A ST Co., Ltd. (170900.KS)
KRW 47300.0
(-1.77%)
KRW 47300.0
(-1.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 322.21 Billion KRW | 2.16% |
| 2022 | 315.39 Billion KRW | 7.32% |
| 2021 | 293.87 Billion KRW | 3.35% |
| 2020 | 284.34 Billion KRW | -8.86% |
| 2019 | 311.98 Billion KRW | 6.37% |
| 2018 | 293.29 Billion KRW | 4.77% |
| 2017 | 279.95 Billion KRW | 1.15% |
| 2016 | 276.76 Billion KRW | -8.33% |
| 2015 | 301.92 Billion KRW | -2.65% |
| 2014 | 310.12 Billion KRW | 17.07% |
| 2013 | 264.91 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 76.8 Billion KRW | -13.72% |
| 2024 Q2 | 84.39 Billion KRW | 10.7% |
| 2023 Q2 | 81.16 Billion KRW | 6.07% |
| 2023 Q3 | 79.74 Billion KRW | -1.75% |
| 2023 Q1 | 76.51 Billion KRW | -0.01% |
| 2023 Q4 | 89.01 Billion KRW | 11.63% |
| 2023 FY | 322.21 Billion KRW | 2.16% |
| 2022 Q4 | 76.52 Billion KRW | -7.23% |
| 2022 Q2 | 80.65 Billion KRW | 6.52% |
| 2022 Q1 | 75.71 Billion KRW | 4.02% |
| 2022 FY | 315.39 Billion KRW | 7.32% |
| 2022 Q3 | 82.48 Billion KRW | 2.27% |
| 2021 Q1 | 70.01 Billion KRW | 20.55% |
| 2021 Q3 | 77.87 Billion KRW | 6.39% |
| 2021 Q4 | 72.79 Billion KRW | -6.53% |
| 2021 FY | 293.87 Billion KRW | 3.35% |
| 2021 Q2 | 73.19 Billion KRW | 4.55% |
| 2020 Q3 | 66.76 Billion KRW | 36.48% |
| 2020 FY | 284.34 Billion KRW | -8.86% |
| 2020 Q2 | 48.91 Billion KRW | -55.77% |
| 2020 Q1 | 110.58 Billion KRW | 49.23% |
| 2020 Q4 | 58.07 Billion KRW | -13.01% |
| 2019 FY | 311.98 Billion KRW | 6.37% |
| 2019 Q4 | 74.1 Billion KRW | -9.46% |
| 2019 Q3 | 81.84 Billion KRW | 9.38% |
| 2019 Q2 | 74.82 Billion KRW | -7.86% |
| 2019 Q1 | 81.2 Billion KRW | 18.94% |
| 2018 Q2 | 85.35 Billion KRW | 19.62% |
| 2018 FY | 293.29 Billion KRW | 4.77% |
| 2018 Q3 | 68.31 Billion KRW | -19.96% |
| 2018 Q4 | 68.27 Billion KRW | -0.06% |
| 2018 Q1 | 71.35 Billion KRW | -1.89% |
| 2017 Q2 | 67.33 Billion KRW | 2.56% |
| 2017 Q1 | 65.65 Billion KRW | 11.21% |
| 2017 Q3 | 74.23 Billion KRW | 10.25% |
| 2017 FY | 279.95 Billion KRW | 1.15% |
| 2017 Q4 | 72.72 Billion KRW | -2.03% |
| 2016 Q4 | 59.03 Billion KRW | -7.05% |
| 2016 FY | 276.76 Billion KRW | -8.33% |
| 2016 Q1 | 77.5 Billion KRW | 1.21% |
| 2016 Q2 | 81.61 Billion KRW | 5.3% |
| 2016 Q3 | 63.51 Billion KRW | -22.18% |
| 2015 FY | 301.92 Billion KRW | -2.65% |
| 2015 Q3 | 77.59 Billion KRW | 1.09% |
| 2015 Q2 | 76.76 Billion KRW | 8.15% |
| 2015 Q1 | 70.97 Billion KRW | -7.85% |
| 2015 Q4 | 76.57 Billion KRW | -1.31% |
| 2014 Q1 | 80.42 Billion KRW | 0.13% |
| 2014 Q2 | 80.29 Billion KRW | -0.17% |
| 2014 Q3 | 72.38 Billion KRW | -9.85% |
| 2014 Q4 | 77.02 Billion KRW | 6.42% |
| 2014 FY | 310.12 Billion KRW | 17.07% |
| 2013 Q2 | 76.9 Billion KRW | 190.06% |
| 2013 FY | 264.91 Billion KRW | 0.0% |
| 2013 Q1 | 26.51 Billion KRW | 0.0% |
| 2013 Q3 | 81.12 Billion KRW | 5.49% |
| 2013 Q4 | 80.32 Billion KRW | -0.98% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -592.853% |
| Dong-A Socio Holdings Co., Ltd. | 364.1 Billion KRW | 11.507% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | -61.947% |
| Ildong Pharmaceutical Co., Ltd. | 207.53 Billion KRW | -55.254% |
| Ildong Holdings Co., Ltd. | 198.88 Billion KRW | -62.007% |
| Hana Pharm Co., Ltd. | 140.85 Billion KRW | -128.753% |
| Kukje Pharma Co., Ltd. | 67.22 Billion KRW | -379.307% |
| Yuhan Corporation | 564.5 Billion KRW | 42.922% |
| SAMSUNG PHARM. Co., LTD. | 23.74 Billion KRW | -1256.848% |
| Hanall Biopharma Co.,Ltd | 75.03 Billion KRW | -329.389% |
| Dong Sung Bio Pharm.Co.,Ltd. | 40.64 Billion KRW | -692.657% |
| MYUNGMOON Pharm co.,Ltd | 94.51 Billion KRW | -240.909% |
| Samjin Pharmaceuticals Co., Ltd. | 145.89 Billion KRW | -120.857% |
| CKD Bio Corp. | 5.01 Billion KRW | -6330.985% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -592.853% |
| REYON Pharmaceutical Co., Ltd. | 76.81 Billion KRW | -319.446% |
| Aprogen pharmaceuticals,Inc. | -12.04 Billion KRW | 2774.931% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 4.01% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -309.836% |
| Hyundai Pharmaceutical Co., Ltd. | 75.23 Billion KRW | -328.256% |
| Yungjin Pharm. Co., Ltd. | 70.93 Billion KRW | -354.209% |
| HANDOK Inc. | 151.36 Billion KRW | -112.869% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -592.853% |
| Kwang Dong Pharmaceutical Co., Ltd. | 295.11 Billion KRW | -9.18% |
| Daewoong pharmaceutical Co.,Ltd | 681.55 Billion KRW | 52.724% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 4.01% |
| Yuhan Corporation | 564.5 Billion KRW | 42.922% |
| Jeil Pharma Holdings Inc | 201.82 Billion KRW | -59.652% |
| Hanmi Pharm. Co., Ltd. | 835.85 Billion KRW | 61.451% |
| Chong Kun Dang Pharmaceutical Corp. | 655.34 Billion KRW | 50.833% |
| Suheung Co., Ltd. | 99.02 Billion KRW | -225.377% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | 4.01% |
| Chong Kun Dang Holdings Corp. | 371.49 Billion KRW | 13.267% |
| Ilsung Pharmaceuticals Co., Ltd. | 34.71 Billion KRW | -828.142% |
| JW Holdings Corporation | 446.15 Billion KRW | 27.781% |
| Samil Pharmaceutical Co.,Ltd | 72.21 Billion KRW | -346.205% |
| Jeil Pharmaceutical Co.,Ltd | 183.81 Billion KRW | -75.292% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -309.836% |
| Daewon Pharmaceutical Co., Ltd. | 254.23 Billion KRW | -26.739% |
| Korea United Pharm Inc. | 173.48 Billion KRW | -85.726% |
| Whan In Pharm Co.,Ltd. | 98.12 Billion KRW | -228.367% |
| Dongwha Pharm.Co.,Ltd | 184.12 Billion KRW | -74.997% |
| Boryung Corporation | 333.26 Billion KRW | 3.318% |
| Bukwang Pharmaceutical Co., Ltd. | 50.04 Billion KRW | -543.837% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | -61.947% |
| JW Lifescience Corporation | 51.32 Billion KRW | -527.787% |